3 news items
Cogent Biosciences Reports First Quarter 2024 Financial Results
COGT
7 May 24
the future of our business, future plans and strategies, our clinical results, the rate of enrollment in our clinical trials and other future conditions. New
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
COGT
26 Feb 24
. Instead, they are based on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, our
Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
COGT
22 Feb 24
and strategies, our clinical results, the rate of enrollment in our clinical trials and other future conditions. New risks and uncertainties may emerge from
- Prev
- 1
- Next